Related Content
Download content relating to this event and topic.
Ireland has emerged as a global biopharmaceutical manufacturing hub, attracting $9.9 billion in investments and nine of the top ten pharmaceutical firms through strategic government support and infrastructure development.
Ireland has emerged as a premier destination for biopharmaceutical manufacturing, with USD 9.9 billion invested in new facilities over the past decade and hosting nine of the top ten global pharmaceutical firms. Major investments include AstraZeneca's USD 64 million for manufacturing and R&D, Johnson & Johnson's USD 354 million expansion in Ringaskiddy, Merck kGaA's USD 421 million investment in Cork, and BMS's USD 900 million plant in Dublin, while China's WuXi Biologics plans to build the world's largest single-use manufacturing facility in Dundalk. This success is attributed to various factors beyond tax incentives, including government support for the knowledge-based sector through institutions like the National Institute for Bioprocessing Research & Training (NIBRT), with IDA Ireland's Strategy 2021-2024 aiming to attract 800 investments and create 50,000 new jobs through focus on growth, transformation, regions, sustainability, and impact.
View the Key Themes for
Biomanufacturing Ireland 2025
Register today to secure your ticket.
Our selected experts will share insights on the latest trends, challenges, and developments in this dynamic field. Engage in unique discussions, learn about cutting-edge scientific discoveries, and explore the future of biopharmaceuticals with these influential thought leaders.
Choose a plan that fits your role, company, and industry.
FINAL CALL
VAT exemptions will be applied where applicable in accordance with relevant regulations
FINAL CALL
VAT exemptions will be applied where applicable in accordance with relevant regulations
LIMITED AVAILABILITY
VAT exemptions will be applied where applicable in accordance with relevant regulations
Be the first in line! Register your interest now to get exclusive access to Super Early-Bird tickets - the lowest prices available - before they go live.
Join the roster of esteemed colleagues to discuss what you or your company are bringing to the biopharmaceutical industry.
Pinnacle IMP is a unique provider of GMP-compliant contract manufacturing services for injectables, with a strong focus on biologics and vaccines. Offering state-of-the-art solutions, Pinnacle IMP excels in end-to-end production for clinical trials, ensuring high-quality, consistent, and regulatory-compliant batches from preclinical through to commercial scale.
A standout offering is Pinnacle’s proprietary needle-free injector technology, designed to deliver biologics and vaccines in the solid state without the need for traditional needles. This advanced delivery system offers significant advantages, including improved patient comfort, enhanced product stability, and a reduction in manufacturing and distribution costs. The needle-free injector also simplifies logistics by eliminating the need for cold chain transportation in some cases, making it easier and more cost-effective to distribute biologics globally.
By integrating this innovative technology throughout the product lifecycle, Pinnacle IMP can help reduce processing time, streamline manufacturing workflows, and minimize costs, while maintaining the highest standards of quality and regulatory compliance. This needle-free approach has the potential to revolutionize drug delivery, making biologics and vaccines more accessible and patient-friendly, while driving down costs for manufacturers and healthcare providers alike. Pinnacle IMP is committed to advancing the future of biologic manufacturing with innovative, cost-effective, and scalable solutions.
Contact the IMAPAC to learn about our sponsorship process, rates and more.
Visit the workshop page to view more content.
Download content relating to this event and topic.
Visit the event page to view more content.
To stay informed about event updates, including date, venue, and agenda, please subscribe to our newsletter on our event website. You can also follow our official social media channels for real-time updates and announcements.
The conference will provide a comprehensive learning experience covering various aspects of the dynamic biopharmaceutical industry, ensuring attendees gain valuable insights and knowledge.
We are committed to ensuring the safety and well-being of all attendees. We will implement rigorous safety measures in line with local health guidelines and regulations. Specific safety measures will be communicated closer to the event date to ensure they align with the most up-to-date health recommendations. Rest assured, your safety is our priority.
Yes, we have a cancellation and refund policy in place. Please refer to our “Cancellation Policy” on our website for details on how to request a refund if you are unable to attend.
We welcome presentation submissions. If you’re interested in speaking at the event, please visit this page on our website for submission guidelines and deadlines.
Our event is designed to cater to a wide range of professionals within the biopharmaceutical industry, including researchers, scientists, executives, regulatory experts, and professionals involved in drug development and manufacturing.
Participants can expect to gain insights from industry experts, network with peers, and stay up-to-date with the latest trends and innovations in biopharmaceuticals
Yes, we have networking sessions, workshops, and social events scheduled throughout the event to facilitate connections and collaborations among attendees.
Yes, we offer sponsorship and exhibition opportunities for businesses and organizations. Please visit our this page on our website for more information.
To register for the event, you'll find multiple "register" buttons on this page to get started. You’ll find detailed instructions and options for registration, including pricing and deadlines.
Don't miss out on unique networking, speaking and sponsorship opportunities.